"Atlantis Eyecare Huntington Beach is home to some of the most high-tech eye care equipment available and delivers amazing results in eye care. Our team of doctors have decades of experience under their belt, contributing to their competence and expertise. We are among the leading specialists in glaucoma treatment, LASIK eye surgery, retina care, and cataract surgery. These are just a few services we provide and how we have made Atlantis Eyecare Huntington Beach a world-class destination for those seeking the very best. If Huntington Beach is not the most convenient location for you, rest assured we have several locations spanning across Orange County. If you are looking for LASIK surgery, be sure to check out our other optometry"

During the past decade, Atlantis Eye Care conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlantis Eye Care" #1 sponsor was "Jaeb Center for Health Research" with 7 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Abbott Medical Optics" with 1 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored and "Alimera Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlantis Eye Care" #1 collaborator was "National Eye Institute (NEI)" with 6 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Atlantis Eye Care" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (2 trials), "Cataract" (1 trials), "Diabetic Macular Edema (DME)" (1 trials) and "Full-thickness Macular Holes (MH)" (1 trials). Many other conditions were trialed in "Atlantis Eye Care" in a lesser frequency.

Most popular intervention types in "Atlantis Eye Care" are "Drug" (9 trials), "Device" (4 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "APL-2" (1 trials), "Deferred aflibercept" (1 trials) and "Deferred laser" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantis Eye Care" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Atlantis Eye Care". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Atlantis Eye Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Atlantis Eye Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".